Consensus ABIONYX Pharma

Equities

ABNX

FR0012616852

Real-time Euronext Paris Other stock markets 07:13:14 03/05/2024 pm IST			5-day change	1st Jan Change
1.068 ^EUR	+0.19%		+1.14%	-17.08%

14/03	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
11/03	Abionyx: reduced net loss in 2023	CF

Evolution of the average Target Price on ABIONYX Pharma

Price target over the last 5 years

History of analyst recommendation changes

5aa622169d86f3.TaIUc8HgAnJ2YLc7lre2VPAd4uhP4BHnzA3hmHcl0jU.Ic5dMvG4egAzUt59u8LkNrhNo4N-1le-qXSsyC9xllt4llwJkLREATNV-g~5b71551c4dcd1f294c50da641ca01971

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.066 EUR

Average target price

10.5 EUR

Spread / Average Target

+884.99%

High Price Target

10.5 EUR

Spread / Highest target

+884.99%

Low Price Target

10.5 EUR

Spread / Lowest Target

+884.99%

Consensus detail

Consensus revision (last 18 months)

Ratings for ABIONYX Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar